Ratni Hasane

Ratni Hasane

Company: F. Hoffmann-La Roche

Job title: Distinguished Scientist

Seminars:

Live Q&A & Panel Discussion: The Value of Splicing Modulators for Therapeutics & Future Applications 3:35 pm

Targeting RNA splicing for disease application intervention has proven a valuable therapeutic intervention. It is now essential to review the clinical landscape of successes which exists with targeting the RNA spliceosome, consider various approaches and motifs being harnessed to target diseases beyond SMA and review future applicability of this modality.Read more

day: Day One

Discovery of Risdiplam, Successes, Challenges & Future Directions 2:30 pm

Reviewing the route to the successful discovery of Risdiplam, a first-in class splicing modulator for treatment of SMA Discussing the successes and challenges with the discovery and development of Risdiplam Exploring future directions including potential other targets and new chemical space for splicing modulatorsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.